1. Sproull M,
Brechbiel M,
Camphausen K; Antiangiogenic therapy through copper chelation; Expert Opinion on Therapeutic Targets.
2003,
405-409.
2. Raju KS,
Alessandri G,
Ziche M,
Gullino PM.
Ceruloplasmin,
copper ions,
and angiogenesis.
J Natl Cancer Inst 1982;69:1183–8.
3. Ziche M,
Jones J,
Gullino PM.
Role of prostaglandin E1 and copper in angiogenesis.
J Natl Cancer Inst 1982;69:475–82.
4. Canelas HM,
DeJorge FB,
Pereira WC,
Sallum J.
Biochemistry of cerebral tumours.
Sodium,
potassium,
calcium,
phosphorus,
magnesium,
copper and sulphur contents of astrocytoma,
medulloblastoma and glioblastoma multiforme.
J Neurochem 1968;15:1455-1461
5. Nanni C,
Schiavina R,
Boschi S,
Ambrosini V,
Pettinato C,
Brunocilla E.
Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results.
Eur J Nucl Med Mol Imaging.
2013;40 Suppl 1:S11-7.
6. Beheshti M,
Haim S,
Zakavi R,
et al.
Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.
J Nucl Med.
2013;54:833–840.
7. Nanni C,
Schiavina R,
Brunocilla E,
Boschi S,
Borghesi M,
Zanoni L.
18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse: A Comparison to 11C-Choline PET/CT.
Clin Nucl Med.
2015;40:e386-91
8. Panichelli P,
Villano C,
Cistaro A et al.
Imaging of Brain Tumors with Copper-64 Chloride: Early Experience and Results.
Cancer Biother Radiopharm.
2016;31:159-67.
9. Castellucci P,
Fanti S.
Prostate cancer: identifying sites of recurrence with choline-PET-CT imaging.
Nat Rev Urol.
2015;12:134–135.
10. Cai H,
Wu JS,
Muzik O,
Hsieh JT,
Lee RJ,
Peng F.
Reduced 64Cu uptake and tumor growth inhibition by knockdown of human copper transporter 1 in xenograft mouse model of prostate cancer.
J Nucl Med.
2014;55:622–8.
11. Cornford P,
Bellmunt J,
Bolla M et al.
EAU-ESTRO-SIOG Guidelines on Prostate Cancer.
Part II: Treatment of Relapsing,
Metastatic,
and Castration-Resistant Prostate Cancer.
Eur Urol.
2016Aug.
[Epubahead of print]
12. Piccardo A,
Paparo F,
Piccazzo R et al.
Value of fused 18F-Choline-PET/MRI to evaluate prostate cancer relapse in patients showing biochemical recurrence after EBRT: preliminary results.
Biomed Res Int.
2014:103718.
13. Paparo F,
Piccardo A,
Bacigalupo L et al.
Value of bimodal(18)F-choline-PET/MRI and trimodal (18)F-choline-PET/MRI/TRUS for the assessment of prostate cancer recurrence after radiation therapy and radical prostatectomy.
Abdom Imaging.
2015;40:1772-87.
14. Paparo F,
Piccardo A,
Bacigalupo L et al Multimodality fusion imaging in abdominal and pelvic malignancies: current applications and future perspectives.
Abdom Imaging.
2015;40:2723-37.
15. Tendulkar RD,
Agrawal S,
Gao T et al.Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy.
J Clin Oncol.
2016 [Epub ahead of print]